Arcus director granted RSUs, options in RCUS stock
Arcus Biosciences director Antoni Ribas reported new equity awards and updated his holdings.
Rhea-AI Filing Summary
Arcus Biosciences director Antoni Ribas reported new equity awards and updated his holdings. He received 5,700 shares of Common Stock as restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders, and they fully vest if the company undergoes a change in control. He was also granted a stock option for 16,900 shares at an exercise price of $23.30 per share, with the option vesting on the same schedule and also accelerating upon a change in control. Following these awards, Ribas directly owns 44,300 Common Stock shares and holds an additional 8,553 shares indirectly through a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,600 shares
Grant/Award
3 txns
Insider
Ribas Antoni
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,900 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,700 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,900 contracts (Direct);
Common Stock — 44,300 shares (Direct);
Common Stock — 8,553 shares (Indirect, By Trust)
Footnotes (2)
- F1. Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- F2. The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
Key Figures
RSU grant: 5,700 shares
Stock option grant: 16,900 shares
Option exercise price: $23.30 per share
+3 more
6 metrics
RSU grant
5,700 shares
Restricted stock units vesting by June 11, 2027 or next annual meeting
Stock option grant
16,900 shares
Option award reported as of June 11, 2026
Option exercise price
$23.30 per share
Exercise price for 16,900-share stock option
Option expiration
June 10, 2036
Expiration date of the stock option if unexercised
Direct holdings after transaction
44,300 shares
Common Stock directly owned after June 11, 2026 awards
Indirect holdings via trust
8,553 shares
Common Stock held indirectly by trust after transaction
Key Terms
restricted stock units, change in control, stock option, annual meeting of stockholders, +1 more
5 terms
restricted stock units financial
"Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
change in control financial
"The RSUs will become fully vested in the event the Company is subject to a change in control."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
stock option financial
"The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
annual meeting of stockholders financial
"vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer"
exercise price financial
"conversion_or_exercise_price": "23.3000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Arcus Biosciences (RCUS) director Antoni Ribas acquire in this Form 4?
Antoni Ribas received equity compensation, not an open-market purchase. He was granted 5,700 restricted stock units of Arcus Biosciences Common Stock and a stock option covering 16,900 shares, both as awards with no cash price per share at grant.
When do Antoni Ribas’s new RSUs in Arcus Biosciences (RCUS) vest?
The 5,700 restricted stock units vest in full on the earlier of June 11, 2027 or the next annual meeting of Arcus Biosciences stockholders. This means vesting is tied to either a fixed date or the company’s next annual shareholder meeting.
What are the key terms of Antoni Ribas’s new Arcus Biosciences stock option?
The stock option covers 16,900 shares of Arcus Biosciences Common Stock with a $23.30 exercise price per share. It vests in full on the earlier of June 11, 2027 or the next annual meeting of stockholders and expires on June 10, 2036 if not exercised.
How does a change in control affect Antoni Ribas’s new Arcus Biosciences awards?
Both the restricted stock units and the stock option become fully vested if Arcus Biosciences experiences a change in control. This acceleration provision means all 5,700 RSUs and 16,900 option shares would vest immediately upon such a qualifying corporate event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
